Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Relative bioavailability of oral amoxicillin after Roux-en-Y bariatric surgery
RBR-3dgcpvCompleted
- Sponsor
- NUPEB
- Start
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of amoxicillin in bacterial disease (2 arms), sponsored by NUPEB. Primary endpoints: Relative bioavailability of oral amoxicillin and Serum amoxicillin concentration-time profile. Started Jan 2017; status: completed.
02
Drugs
amoxicillin
03
Conditions
bacterial disease
Beyond the preview
Go deeper on RBR-3dgcpv.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-3dgcpv.